363 related articles for article (PubMed ID: 11649303)
1. Two cheers for the CMA's new guidelines on drug company-MD relations The CMA's MD-drug industry guidelines offer advice, nothing more.
Rapp MS; Woollard R
CMAJ; 1991 Dec; 145(11):1497-9. PubMed ID: 11649303
[No Abstract] [Full Text] [Related]
2. The CMA's MD-drug industry guidelines offer advice, nothing more.
Woollard R
CMAJ; 1991 Dec; 145(11):1498-9. PubMed ID: 11649304
[No Abstract] [Full Text] [Related]
3. Ethical responsibilities of physicians in their dealings with pharmaceutical companies.
Royal College of Physicians and Surgeons of Canada. Biomedical Ethics Committee
Ann R Coll Physicians Surg Can; 1990 Jan; 23(1):45-8. PubMed ID: 11650305
[No Abstract] [Full Text] [Related]
4. CMA guidelines on MD-drug industry relations part of international trend.
Williams JR
CMAJ; 1992 Feb; 146(3):386-8. PubMed ID: 11654902
[No Abstract] [Full Text] [Related]
5. Physicians and the pharmaceutical industry.
Canadian Medical Association
CMAJ; 1992 Feb; 146(3):388A-C. PubMed ID: 11654903
[No Abstract] [Full Text] [Related]
6. General Council to consider amendments to CMA policy on MDs' relationships with drug industry.
Williams JR
CMAJ; 1993 Aug; 149(3):335-7. PubMed ID: 11659649
[No Abstract] [Full Text] [Related]
7. Guidelines on gifts to physicians from industry: an update.
American Medical Association. Council on Ethical and Judicial Affairs
Food Drug Law J; 1992; 47(4):445-58. PubMed ID: 11654909
[No Abstract] [Full Text] [Related]
8. CMA guidelines concerning relationship of MDs and drug industry to be revised, board told.
Sullivan P
CMAJ; 1993 Jan; 148(2):273-5. PubMed ID: 11652162
[No Abstract] [Full Text] [Related]
9. Guidelines for relationships between industry and the American College of Obstetricians and Gynecologists and its fellows. ACOG Committee Opinion No. 45.
American College of Obstetricians and Gynecologists [ACOG]. Committee on Ethics
ACOG Comm Opin; 1985 Oct; No. 45():1 p. PubMed ID: 11660326
[No Abstract] [Full Text] [Related]
10. The relationship between physicians and the pharmaceutical industry: a report of the Royal College of Physicians.
Royal College of Physicians
J R Coll Physicians Lond; 1986 Oct; 20(4):3-10. PubMed ID: 11643936
[No Abstract] [Full Text] [Related]
11. Pushing drugs to doctors.
Consum Rep; 1992 Feb; 57(2):87-94. PubMed ID: 11651202
[No Abstract] [Full Text] [Related]
12. [Effects of a mandatory guideline that prohibit hospital doctors from accepting any form of benefits in any form from the pharmaceutical industry].
Gundermann C; Meier-Hellmann A; Bauer M; Hartmann M
Dtsch Med Wochenschr; 2010 May; 135(3):67-70. PubMed ID: 20077378
[TBL] [Abstract][Full Text] [Related]
13. Guidelines for interactions with pharmaceutical companies.
American Medical Association. Resident Physicians Section
JAMA; 1993 Sep; 270(10):1250. PubMed ID: 11643149
[No Abstract] [Full Text] [Related]
14. Pitching doctors.
Wilkes MS; Shuchman M
N Y Times Mag; 1989 Nov; ():88, 90, 126, 128-129. PubMed ID: 11650264
[No Abstract] [Full Text] [Related]
15. University physician-researcher conflicts of interest: the inadequacy of current controls and proposed reform.
Maatz CT
High Technol Law J; 1992; 7():137-88. PubMed ID: 11659962
[No Abstract] [Full Text] [Related]
16. Interactions between physicians and the pharmaceutical industry: what does the literature say?
Lexchin J
CMAJ; 1993 Nov; 149(10):1401-7. PubMed ID: 8221424
[TBL] [Abstract][Full Text] [Related]
17. Gifts to physicians from the pharmaceutical and medical manufacturing industry: what every physician should know.
Zoorob R; Larzelere M
J La State Med Soc; 2004; 156(1):28-32. PubMed ID: 15000210
[TBL] [Abstract][Full Text] [Related]
18. AMA's gift guidelines.
Conley RB
Food Drug Cosmet Med Device Law Dig; 1993; 10():19-27. PubMed ID: 11654936
[No Abstract] [Full Text] [Related]
19. What market values are doing to medicine.
Relman AS
Atlantic; 1992 Mar; 269(3):98-102, 105-106. PubMed ID: 11651349
[No Abstract] [Full Text] [Related]
20. Cooperative partnerships or conflict-of-interest? A national survey of interaction between the pharmaceutical industry and medical organizations.
Kerridge I; Maguire J; Newby D; McNeill PM; Henry D; Hill S; Day R; Macdonald G; Stokes B; Henderson K
Intern Med J; 2005 Apr; 35(4):206-10. PubMed ID: 15836497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
